Intelligence Hub

Discretionary open-market sale valued at ~$1.36M without 10b5-1 plan

Director Merline Saintil's proposed sale of 18,126 shares follows 37,500 shares sold in past 3 months (total ~55,626 shares, ~$4.06M); routine vesting liquidity but ongoing activity to note.

Standard 10b5-1 scheduled sales and RSU tax sell-to-cover; value ~$3.7M but non-discretionary

Standard 10b5-1 scheduled sales totaling ~$1.39M

Standard dispositions including 10b5-1 sale and exchange fund contribution (diversification); not discretionary.

Standard 10b5-1 scheduled sales totaling ~$7.3M

Discretionary sale of 2,500 shares (~$193K, 1.7% of holdings) by director; small and isolated.

Standard 10b5-1 scheduled sales totaling ~$1.9M.

Standard 10b5-1 scheduled sales totaling ~$1.02M; pre-planned and non-discretionary

Standard 10b5-1 scheduled sales liquidating family trust, albeit large (> $1M and >10% holdings).

Discretionary sale of $480K by director (2.4% of holdings); below medium thresholds

Standard 10b5-1 scheduled sale; non-discretionary and routine.

Standard 10b5-1 scheduled sales

Discretionary sale >$1M (60,400 shares, $2.72M) and >10% of holdings; no 10b5-1 plan.

Director's VC funds executed large discretionary open-market sales totaling 1.87M shares (~$90M), fully liquidating RKLB holdings without 10b5-1 plan.

Standard 10b5-1 scheduled sales by CEO's trust totaling 2.5M shares (~$128M).

Large position changes via 8M share pro rata distributions by KV V in 13D amendment.

Dec 2024 exchange of 50.95M Beck-held common shares for Series A preferred stock (> $1M affiliate transaction), approved by special committee; provides director rights, voting parity.

Standard scheduled sale pursuant to a Rule 10b5-1 trading plan

Large discretionary sale >$1M (total ~$26.6M) without 10b5-1 plan.

CEO Peter Beck's trust disclosed 10b5-1 plan to sell up to 5M shares (large absolute but <10% of holdings) via 13D amendment.

Standard 10b5-1 scheduled sale; small size ($156K, <1% holdings), non-discretionary.

Large position change in Schedule 13D from >5% to 1.6%, indicating significant reduction in beneficial ownership.

Small discretionary sale by director (~$236K, 7% of holdings); not part of 10b5-1 plan.

Company exchanged 50,951,250 common shares ($0.0001 par) for preferred stock with Equatorial Trust, an insider-owned entity controlled by CEO Peter Beck and affiliates.

Exchange of 50,951,250 common shares (significant value) for preferred stock with affiliate family trust of CEO Sir Peter Beck

Exchange of 50.95M shares for Preferred Stock with CEO's family trust, preserving significant influence.

Discretionary sale by director exceeding $1M total value without 10b5-1 plan.

Discretionary open-market sale of 50,000 shares (~$1.28M) representing >10% of director's direct holdings

Discretionary sale exceeding $1M and >10% of holdings (50,000 of 482,275 shares).

Large discretionary sale >$1M (~$97M) and >10% (~50%) of holdings per fund, not under 10b5-1 plan.

Discretionary sale of 39,446 shares (~$272K, 48% of prior total holdings) by Director via indirect entity, no 10b5-1 plan

Director Sven Strohband not standing for reelection at Annual Meeting

Large position change in SC 13G/A: from >5% to 0% beneficial ownership.

Large position change in SC 13G/A: ownership reduced from >5% to 4.9%.

Disclosed material weaknesses in internal controls at SolAero subsidiary: segregation of duties for journal entries, privileged IT access limits, IT change management.

FAA oversight on anomaly investigation causing postponement of next launch, akin to license delays.

CEO Peter Beck's trust disclosed large sale of 3.6M shares (~$20M) via SC 13D/A, representing position change.

Discretionary sale >$1M by CEO's family trust (>6% of holdings)

Discretionary sale of 38,090 shares (>10% of total holdings, liquidating indirect position)

Material weaknesses in SolAero subsidiary internal controls: segregation of duties for journal entries, privileged IT access, change management.

Discretionary sale of 50,689 shares (~$253K) liquidated indirect holdings, exceeding 10% of prior total reported shares (~57%).

Discretionary sale of 50,689 shares (~36% of holdings) via controlled entity, exceeding 10% threshold without 10b5-1 plan.

Material weaknesses in internal controls over financial reporting at SolAero subsidiary (segregation of duties, IT access, change management), rendering disclosure controls ineffective.

Discretionary sale of 100% of holdings in LogiQ, Inc. (>$10% of reported position)

EVP Global Operations Shaun O’Donnell departed executive officer role for internal non-executive position; no successor announced.

Discretionary open-market sale of 200,000 shares ($1.13M) representing ~22% of pre-sale holdings; no 10b5-1 plan indicated.

Discretionary sale of 456,190 shares (~$2.56M) via controlled entity, exceeding $1M and >10% (70%) of prior direct holdings.

Gross margin declined 12.9pp YoY to 8.9% due to acquisition integration, higher stock-based comp, and launch costs

Disclosed material weaknesses in internal controls over financial reporting, including review of reconciliations, resource sufficiency, and segregation of duties.

$40M aggregate redemption of shares/options from executives pre-Business Combination: Beck $30M shares, Spice $5M options, O'Donnell $5M shares.

OCF burn $72M, runway ~12mo despite cash hoard; increasing vs prior YoY

Gross margin -3% still negative; op/net deeply negative

Material weaknesses in internal controls persist post-SPAC

Inventory up 83% YoY to $48M > rev growth

Large position changes via pro rata distributions of 8.14M shares by Bessemer funds to LPs, as disclosed in SC 13D/A.

Large position change: Glazer Capital reduces from >5% to 0% in SC 13G/A.

Large position change: Millennium affiliates reduce from >5% to 0.1% (653,000 shares) in SC 13G/A.

Large position change: Linden group reduced from >5% to 0 shares as of Dec 31, 2021.

Gross margin plunged to -235% in Q3 from -18% YoY (>500bps decline) due to stock comp, COVID utilization

9M op cash burn -$50M, up 133% YoY without proportional rev growth (Q3 rev down)

Disclosed material weaknesses in ICFR: control environment, journal entries, 3rd-party reviews, reconciliations

SPAC sponsor (insider) reports large position change from prior holdings to 0 shares (complete exit) in SC 13G/A.

Two shareholder lawsuits and four demand letters alleging materially false/misleading proxy disclosures on Rocket Lab merger; supplemental disclosures issued to moot claims without admission.

Disclosure controls ineffective due to warrant reclassification restatement; material weakness in financial reporting.

Cash runway <3 months ($45k cash / ~$400k quarterly burn); liquidity deficiency noted, reliant on sponsor funding.

Material weakness in internal controls over financial reporting related to warrant accounting classification; disclosure controls not effective.

Restatement of audited financials for period ended Dec 31, 2020 due to warrant reclassification per SEC guidance.

Item 4.02 filing announcing non-reliance on previously issued financial statements (10-K, 10-Q, 8-K) due to warrant reclassification as liabilities per SEC guidance.

Restated 2020 financials and prior interim to reclassify warrants as derivative liabilities per SEC SPAC guidance, impacting equity and net loss (non-cash).

Disclosure controls/procedures ineffective as of Dec 31, 2020 due to warrant misclassification; management to enhance processes.